-
BioCorRx Announces IRB Approval to Begin Phase I Clinical Trial of BICX104, an Implantable Biodegradable Naltrexone Pellet for the Treatment of Opioid Use Disorder
[ad_1] ANAHEIM, CA – (NewMediaWire) – March 16, 2022 – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider…
Read More » -
Troika Media Group Announces Pricing of $50 Million Private Placement
[ad_1] LOS ANGELES – (NewMediaWire) – March 17, 2022 – Troika Media Group, Inc. (Nasdaq:TRKA) (“TMG” or “Company”), a brand…
Read More » -
For youth with a heart defect, shift to adult-focused care is key to health, quality of life
[ad_1] Statement Highlights: Most children born with heart defects, including those with complex heart conditions, now survive into adulthood. The…
Read More » -
If blood pressure rises upon standing, so may risk for heart attack
[ad_1] Research Highlights: Young and middle-aged adults with high blood pressure whose systolic blood pressure (top-number) rose more than 6.5…
Read More » -
News
Golden Matrix Begins Trading Today on The Nasdaq Capital Market
[ad_1] LAS VEGAS, NV – (NewMediaWire) – March 17, 2022 – Golden Matrix Group, Inc. (NASDAQ:GMGI)(“Golden Matrix” or the “Company”),…
Read More »
Trending Tickers
WISH
$9.18
27.72%
WISH
$9.18
27.72%
WISH
$9.18
27.72%
Follow us on Twitter